WDR5B
gene geneOn this page
Also known as FLJ11287
Summary
WDR5B (WD repeat domain 5B, HGNC:17826) is a protein-coding gene on chromosome 3q21.1, encoding WD repeat-containing protein 5B (Q86VZ2). Plays a role in the proliferation of retinal pigment epithelial (RPE) cells.
This intronless gene encodes a protein containing several WD40 repeats. WD repeats are approximately 30- to 40-amino acid domains containing several conserved residues, including a trp-asp at the C-terminal end. The encoded protein may mediate protein-protein interactions.
Source: NCBI Gene 54554 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 40 total
- MANE Select transcript:
NM_019069
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17826 |
| Approved symbol | WDR5B |
| Name | WD repeat domain 5B |
| Location | 3q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ11287 |
| Ensembl gene | ENSG00000196981 |
| Ensembl biotype | protein_coding |
| OMIM | 621240 |
| Entrez | 54554 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000330689, ENST00000920957
RefSeq mRNA: 1 — MANE Select: NM_019069
NM_019069
CCDS: CCDS3012
Canonical transcript exons
ENST00000330689 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001293682 | 122411846 | 122416062 |
Expression profiles
Bgee: expression breadth ubiquitous, 220 present calls, max score 83.52.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.2142 / max 69.9609, expressed in 1686 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 44128 | 7.2142 | 1686 |
Top tissues by expression
267 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 83.52 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 83.37 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 83.01 | gold quality |
| right uterine tube | UBERON:0001302 | 82.97 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.18 | gold quality |
| bronchus | UBERON:0002185 | 82.02 | gold quality |
| hair follicle | UBERON:0002073 | 79.85 | silver quality |
| diaphragm | UBERON:0001103 | 77.08 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.57 | gold quality |
| body of pancreas | UBERON:0001150 | 76.37 | gold quality |
| corpus epididymis | UBERON:0004359 | 76.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.44 | gold quality |
| pancreas | UBERON:0001264 | 75.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 75.16 | gold quality |
| tibia | UBERON:0000979 | 74.74 | gold quality |
| caput epididymis | UBERON:0004358 | 74.68 | gold quality |
| parotid gland | UBERON:0001831 | 74.44 | silver quality |
| monocyte | CL:0000576 | 74.40 | gold quality |
| leukocyte | CL:0000738 | 74.32 | gold quality |
| mononuclear cell | CL:0000842 | 74.18 | gold quality |
| ventricular zone | UBERON:0003053 | 73.88 | gold quality |
| right lobe of liver | UBERON:0001114 | 73.79 | gold quality |
| right adrenal gland | UBERON:0001233 | 73.62 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.56 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 73.53 | gold quality |
| endometrium | UBERON:0001295 | 73.33 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.15 | gold quality |
| granulocyte | CL:0000094 | 73.14 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 73.13 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 73.04 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 660.86 |
| E-ANND-3 | yes | 3.74 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
90 targeting WDR5B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-329-3P | 99.91 | 66.56 | 1234 |
| HSA-MIR-362-3P | 99.91 | 66.38 | 1267 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-589-3P | 99.91 | 69.62 | 2088 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
| HSA-MIR-302D-3P | 99.89 | 71.25 | 1777 |
Literature-anchored findings (GeneRIF, showing 1)
- Initial Characterization of WDR5B Reveals a Role in the Proliferation of Retinal Pigment Epithelial Cells. (PMID:39056772)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | wdr5 | ENSDARG00000016903 |
| mus_musculus | Wdr5b | ENSMUSG00000034379 |
| rattus_norvegicus | Wdr5b | ENSRNOG00000002253 |
| drosophila_melanogaster | CG10931 | FBGN0034274 |
| drosophila_melanogaster | wds | FBGN0040066 |
Paralogs (26): PAFAH1B1 (ENSG00000007168), SNRNP40 (ENSG00000060688), WDR62 (ENSG00000075702), WDR7 (ENSG00000091157), TBL2 (ENSG00000106638), PAK1IP1 (ENSG00000111845), WDR75 (ENSG00000115368), DCAF4 (ENSG00000119599), DAW1 (ENSG00000123977), TEP1 (ENSG00000129566), AHI1 (ENSG00000135541), WDR38 (ENSG00000136918), MAPKBP1 (ENSG00000137802), POC1B (ENSG00000139323), NEDD1 (ENSG00000139350), COP1 (ENSG00000143207), WDR17 (ENSG00000150627), WDR43 (ENSG00000163811), POC1A (ENSG00000164087), WDR88 (ENSG00000166359), WDR81 (ENSG00000167716), DCAF4L2 (ENSG00000176566), DCAF4L1 (ENSG00000182308), WDR27 (ENSG00000184465), NWD1 (ENSG00000188039), WDR5 (ENSG00000196363)
Protein
Protein identifiers
WD repeat-containing protein 5B — Q86VZ2 (reviewed: Q86VZ2)
All UniProt accessions (1): Q86VZ2
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in the proliferation of retinal pigment epithelial (RPE) cells. May function as a substrate receptor for CUL4-DDB1 ubiquitin E3 ligase complex.
Subunit / interactions. Probable part of a cullin-RING E3 protein ligase complex containing CUL4B-DDB1 and a substrate-recruiting component (DCAF). Interacts with CUL4B and DDB1.
Subcellular location. Nucleus.
Induction. Up-regulated upon neural differentiation.
Similarity. Belongs to the WD repeat WDR5/wds family.
RefSeq proteins (1): NP_061942* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR019775 | WD40_repeat_CS | Conserved_site |
| IPR020472 | WD40_PAC1 | Repeat |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR059122 | Beta-prop_WDR5-like | Domain |
Pfam: PF25175
UniProt features (13 total): repeat 7, compositionally biased region 2, chain 1, sequence conflict 1, region of interest 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86VZ2-F1 | 93.36 | 0.90 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, HAND1E47_01, chr3q21, TGGAAA_NFAT_Q4_01, GOCC_TRANSFERASE_COMPLEX, GOCC_SET1C_COMPASS_COMPLEX, GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX, GOCC_METHYLTRANSFERASE_COMPLEX, GOMF_HISTONE_BINDING, MARTENS_TRETINOIN_RESPONSE_UP, GATA1_05, BARX1_TARGET_GENES, DLX4_TARGET_GENES, DLX6_TARGET_GENES, ELF2_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (2): histone binding (GO:0042393), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), Set1C/COMPASS complex (GO:0048188)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| histone methyltransferase complex | 1 |
Protein interactions and networks
STRING
1668 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WDR5B | ASH2L | Q9UBL3 | 435 |
| WDR5B | SAMD4B | Q5PRF9 | 406 |
| WDR5B | RBBP5 | Q15291 | 404 |
| WDR5B | FAM162A | Q96A26 | 377 |
| WDR5B | MIX23 | Q4VC31 | 376 |
| WDR5B | SMAGP | Q0VAQ4 | 359 |
| WDR5B | SEC22A | Q96IW7 | 351 |
| WDR5B | FOXP4 | Q8IVH2 | 349 |
| WDR5B | DPY30 | Q9C005 | 348 |
| WDR5B | CASKIN2 | Q8WXE0 | 343 |
| WDR5B | ANKRD22 | Q5VYY1 | 333 |
| WDR5B | CNTLN | Q9NXG0 | 333 |
| WDR5B | GPRC5C | Q9NQ84 | 332 |
| WDR5B | FOXP2 | O15409 | 330 |
| WDR5B | DPH7 | Q9BTV6 | 329 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ASH2L | KMT2D | psi-mi:“MI:0914”(association) | 0.890 |
| KMT2D | RBBP5 | psi-mi:“MI:0914”(association) | 0.840 |
| RBBP5 | KMT2D | psi-mi:“MI:0914”(association) | 0.840 |
| CUL4B | CUL4A | psi-mi:“MI:0914”(association) | 0.730 |
| SNRNP27 | UBA6 | psi-mi:“MI:0914”(association) | 0.530 |
| WDR5B | TCP1 | psi-mi:“MI:0914”(association) | 0.530 |
| ESR1 | KMT2D | psi-mi:“MI:0914”(association) | 0.520 |
| CFTR | WDR5B | psi-mi:“MI:0915”(physical association) | 0.370 |
| WDR5B | ATP13A2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| WDR5B | DDB1 | psi-mi:“MI:0914”(association) | 0.350 |
| NUDT9 | WDR5B | psi-mi:“MI:0914”(association) | 0.350 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| DCAF4 | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
| GPIHBP1 | SAC3D1 | psi-mi:“MI:0914”(association) | 0.350 |
| WDR5B | HSPA8 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2A | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (280): RPIA (Affinity Capture-MS), WDR5B (Affinity Capture-MS), WDR5B (Affinity Capture-MS), RNF220 (Affinity Capture-MS), HSF2 (Affinity Capture-MS), SEPN1 (Affinity Capture-MS), CLTCL1 (Affinity Capture-MS), ZNRF2 (Affinity Capture-MS), CCT4 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), CCT3 (Affinity Capture-MS), RRP12 (Affinity Capture-MS), CCT6B (Affinity Capture-MS), TCP1 (Affinity Capture-MS), CCT6A (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8RWN9, A5GFZ5, A9L985, O19137, O42602, O42603, O60762, O70152, O77676, P00516, P0C605, P19969, P31504, P31505, P31644, P35250, P41227, P47866, P51006, P53033, Q01777, Q01789, Q02029, Q02030, Q02033, Q08E50, Q13976, Q16576, Q1JQ93, Q24572, Q2KI14, Q3SWX8, Q3UX61, Q4R304, Q5FVR7, Q5MB13, Q5R654, Q5RE95, Q60748, Q60973
Diamond homologs: A1CTE6, A1DMI8, A2QVV2, B0Y7H6, B8N4F5, C4R6H3, C4YFX2, D9N129, P0CY34, P16371, P16649, P56094, Q00664, Q08274, Q09019, Q0CKB1, Q10437, Q2HJH6, Q2UM42, Q4WN25, Q5M786, Q5RE95, Q5RF51, Q5SQM0, Q6ED65, Q6PE01, Q6ZMW3, Q86VZ2, Q96DI7, Q9P4R5, Q9SY00, Q9VBC4, A8X8C6, B6QC56, B8N9H4, C0S902, C1GB49, C5FWH1, C5GVJ9, C5JD40
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Neddylation | 5 | 13.9× | 5e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| DNA damage response | 6 | 16.1× | 1e-04 |
| protein ubiquitination | 5 | 10.3× | 4e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
128 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:122415943:A:AC | donor_gain | 0.9100 |
| 3:122415944:C:CC | donor_gain | 0.9100 |
| 3:122415608:A:T | acceptor_gain | 0.8500 |
| 3:122415940:G:C | donor_gain | 0.8300 |
| 3:122415945:T:C | donor_gain | 0.8300 |
| 3:122412693:C:CT | acceptor_gain | 0.7900 |
| 3:122415938:TAGG:T | donor_gain | 0.7600 |
| 3:122415923:CCCTA:C | donor_loss | 0.7400 |
| 3:122415924:CCT:C | donor_loss | 0.7400 |
| 3:122415925:CTA:C | donor_loss | 0.7400 |
| 3:122415926:TA:T | donor_loss | 0.7400 |
| 3:122415927:A:AT | donor_loss | 0.7400 |
| 3:122415928:C:T | donor_loss | 0.7400 |
| 3:122415922:GCCCT:G | donor_loss | 0.7100 |
| 3:122415929:C:A | donor_loss | 0.7100 |
| 3:122414746:ATTGG:A | acceptor_gain | 0.6900 |
| 3:122415458:T:TA | donor_gain | 0.6800 |
| 3:122415998:GAAGC:G | donor_gain | 0.6500 |
| 3:122415928:CCAGT:C | donor_gain | 0.6300 |
| 3:122414739:C:CC | acceptor_gain | 0.6000 |
| 3:122416002:C:CT | donor_gain | 0.6000 |
| 3:122415927:A:AC | donor_gain | 0.5900 |
| 3:122415928:C:CC | donor_gain | 0.5900 |
| 3:122412753:ATCT:A | acceptor_gain | 0.5700 |
| 3:122414738:A:C | acceptor_gain | 0.5500 |
| 3:122414747:TTGGC:T | acceptor_gain | 0.5500 |
| 3:122415921:AGCC:A | donor_loss | 0.5500 |
| 3:122415997:CGAAG:C | donor_gain | 0.5500 |
| 3:122415820:AAAG:A | donor_gain | 0.5300 |
| 3:122415607:C:CT | acceptor_gain | 0.5000 |
AlphaMissense
2152 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:122415258:A:G | W91R | 0.999 |
| 3:122415258:A:T | W91R | 0.999 |
| 3:122415355:A:C | S58R | 0.999 |
| 3:122415355:A:T | S58R | 0.999 |
| 3:122415357:T:G | S58R | 0.999 |
| 3:122414949:A:G | W194R | 0.998 |
| 3:122414949:A:T | W194R | 0.998 |
| 3:122414971:G:C | S186R | 0.998 |
| 3:122414971:G:T | S186R | 0.998 |
| 3:122414973:T:G | S186R | 0.998 |
| 3:122415075:A:G | W152R | 0.998 |
| 3:122415075:A:T | W152R | 0.998 |
| 3:122415101:C:T | G143E | 0.998 |
| 3:122415104:G:C | S142W | 0.998 |
| 3:122414979:A:G | S184P | 0.997 |
| 3:122415020:A:T | V170D | 0.997 |
| 3:122415099:A:G | S144P | 0.997 |
| 3:122415105:A:G | S142P | 0.997 |
| 3:122415225:A:G | S102P | 0.997 |
| 3:122415231:A:G | S100P | 0.997 |
| 3:122414685:A:G | W282R | 0.996 |
| 3:122414685:A:T | W282R | 0.996 |
| 3:122414852:A:G | L226P | 0.996 |
| 3:122414947:C:A | W194C | 0.996 |
| 3:122414947:C:G | W194C | 0.996 |
| 3:122415073:C:A | W152C | 0.996 |
| 3:122415073:C:G | W152C | 0.996 |
| 3:122415201:A:G | W110R | 0.996 |
| 3:122415201:A:T | W110R | 0.996 |
| 3:122415227:G:T | A101D | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000041500 (3:122411725 T>G), RS1000063567 (3:122413227 T>G), RS1000742397 (3:122411861 T>C), RS1000869933 (3:122417419 A>G), RS1001174774 (3:122411511 A>G), RS1001302243 (3:122417146 G>T), RS1001354609 (3:122416848 G>A,C,T), RS1001418364 (3:122416586 T>A,G), RS1002915388 (3:122412268 A>C), RS1003763622 (3:122415416 A>T), RS1003788066 (3:122413796 C>T), RS1003949954 (3:122413653 G>A), RS1004385373 (3:122413827 T>A), RS1004912443 (3:122415190 T>C), RS1005978996 (3:122413741 G>A)
Disease associations
OMIM: gene MIM:621240 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000769_5 | Calcium levels | 2.000000e-22 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004838 | calcium measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Formaldehyde | increases expression, decreases expression | 2 |
| Cyclosporine | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| butyraldehyde | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| tebuconazole | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Drugs, Chinese Herbal | increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Naphthoquinones | increases expression | 1 |
| Potassium Chloride | decreases expression, decreases response to substance | 1 |
| Quercetin | decreases expression | 1 |
| Selenium | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Sodium Dodecyl Sulfate | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, increases expression | 1 |
| Dronabinol | decreases response to substance, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.